daniplestim

A synthetic cytokine and interleukin-3 (IL-3) receptor agonist with enhanced hematopoietic potency. Daniplestim exhibits 10- to 20-fold greater… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2011
012319982011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
BACKGROUND The purpose of this study was to optimize parameters pertaining to microdialysis technique so as to make this method… (More)
Is this relevant?
2010
2010
The availability of several enhancement techniques has made it possible to study delivery of macromolecules through skin. This… (More)
Is this relevant?
2009
2009
Transport of proteins across the skin is highly limited owing to their hydrophilic nature and large molecular size. This study… (More)
Is this relevant?
2001
2001
Modified and chimeric cytokines have been developed to aid in the recovery of hematopoietic precursor cells after myeloablative… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2000
2000
PURPOSE To evaluate the safety and hematopoietic activity of daniplestim administered concurrently with granulocyte colony… (More)
Is this relevant?
2000
2000
OBJECTIVE Neutropenia following high-dose chemotherapy and peripheral blood progenitor cell (PBPC) transplantation might be… (More)
Is this relevant?
1999
1999
We investigated the effects of administering a high-affinity interleukin-3 receptor agonist (daniplestim) and granulocyte colony… (More)
Is this relevant?
1999
1999
The refolding of daniplestim, a human interleukin-3 variant (SC-55494) from Escherichia coli inclusion bodies, was optimized… (More)
Is this relevant?
1999
1999
Myelopoietin (MPO), a multifunctional agonist of interleukin 3 and granulocyte colony-stimulating factor (G-CSF) receptors, was… (More)
Is this relevant?
1998
1998
This study evaluated the ability of daniplestim, a high affinity interleukin 3 receptor agonist, to enhance the hematopoietic… (More)
Is this relevant?